Bristol Myers Squibb beats on revenue, launches $1.5 billion cost cuts as it posts quarterly loss

by | Apr 25, 2024 | Consumer Products, FEATURED, HEADLINE, Investing, Stocks

Bristol Myers Squibb on Thursday reported first-quarter revenue that topped expectations as its blockbuster blood thinner Eliquis and some new drugs …

FEATURED